The Covid vaccine program was touted as a way to protect the elderly. Even if you didn't want the vaccine for yourself, it was your duty to your elders to participate. Below is an expose from The Defender (Children's Health Defense) that should be front page news. The Defender used the term, "slow walked" the data, thus our fancy mother of pearl, gold snail photo.
Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free.
The U.S. Food and Drug Administration (FDA) took more than a year to follow up on a potential increase in serious adverse events in elderly people who received Pfizer’s COVID-19 vaccine, according to an investigative report published Tuesday by The BMJ.
According to The BMJ, in July 2021, the FDA “quietly disclosed” the findings of a potential increase in four types of serious adverse events in elderly people who had received a Pfizer COVID-19 vaccine: acute myocardial infarction, disseminated intravascular coagulation, immune thrombocytopenia, and pulmonary embolism.
The FDA disclosure lacked specific details, such as the magnitude of the increased potential risk, and the agency said it would “share further updates and information with the public as they become available.”
The FDA did not alert physicians or the public, via a press release or any other means, The BMJ investigator said.
Eighteen days later, the FDA published a study planning document that outlined a protocol for a follow-up epidemiological study for investigating the matter more thoroughly.
The BMJ said:
“This recondite technical document disclosed the unadjusted relative risk ratio estimates originally found for the four serious adverse events, which ranged from 42% to 91% increased risk. (Neither absolute risk increases nor confidence intervals were provided.)”
That was over a year ago. “More than a year later, however, the status and results of the follow-up study are unknown,” The BMJ reported, adding:
“The agency has not published a press release, or notified doctors, or published the findings by preprint or the scientific literature or updated the vaccine’s product label.”
The BMJ report also alleged the FDA has not “ publicly acknowledged other published observational studies or clinical trial reanalyses reporting compatible results.”
FDA ‘irresponsible’ for keeping information from scientific community, critics say
Critics of the FDA’s failure to warn the public voiced their concerns about the data to The BMJ and called on the FDA to notify the public immediately.
“To keep this information from the scientific community and prevent us from analysing it ourselves, is irresponsible,” said Dr. Joseph Fraiman, an emergency medicine physician in New Orleans who recently carried out a reanalysis of serious adverse events in Pfizer and Moderna’s randomized trials. “It presumes that these organisations are perfect and cannot benefit from independent scrutiny.”
Dr. Tracy Høeg, an epidemiologist and physician currently conducting COVID-19 vaccine research with the Florida Department of Health and California’s Marin County Department of Health and Human Services, told The BMJ:
“The fact that the FDA found these four safety signals means they should have followed up on the results and I don’t understand why we haven’t had more information since then.
“It has been over a year.” Read more at The Defender FDA Slow-Walked Studies on COVID Vaccine Safety Signals in Elderly